protocol
发表于 2025-3-21 19:57:06
书目名称Cancer Regional Therapy影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0221186<br><br> <br><br>书目名称Cancer Regional Therapy影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0221186<br><br> <br><br>书目名称Cancer Regional Therapy网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0221186<br><br> <br><br>书目名称Cancer Regional Therapy网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0221186<br><br> <br><br>书目名称Cancer Regional Therapy被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0221186<br><br> <br><br>书目名称Cancer Regional Therapy被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0221186<br><br> <br><br>书目名称Cancer Regional Therapy年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0221186<br><br> <br><br>书目名称Cancer Regional Therapy年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0221186<br><br> <br><br>书目名称Cancer Regional Therapy读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0221186<br><br> <br><br>书目名称Cancer Regional Therapy读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0221186<br><br> <br><br>
蔓藤图饰
发表于 2025-3-21 22:17:35
https://doi.org/10.1057/9781137010490stemic circulation either by diffusion into the vascular compartment or by absorption through peritoneal lymphatics. In addition, the peritoneal-plasma barrier allows dose intensification providing high concentrations of the therapeutic agent while minimizing systemic toxicity. Traditionally, the se
NADIR
发表于 2025-3-22 03:35:36
http://reply.papertrans.cn/23/2212/221186/221186_3.png
发电机
发表于 2025-3-22 04:56:08
http://reply.papertrans.cn/23/2212/221186/221186_4.png
transient-pain
发表于 2025-3-22 10:38:09
http://reply.papertrans.cn/23/2212/221186/221186_5.png
modish
发表于 2025-3-22 16:16:23
http://reply.papertrans.cn/23/2212/221186/221186_6.png
modish
发表于 2025-3-22 19:33:07
http://reply.papertrans.cn/23/2212/221186/221186_7.png
Esalate
发表于 2025-3-23 00:11:19
Arthur Benz,Stefan Kuhlmann,Dieter Sadowskin from a urachal primary, is an exceedingly rare disease whose pathophysiologic characteristics have mainly been determined by case series. As there is no standard systemic therapy for urachal carcinomatosis, CRS/HIPEC provides a useful treatment strategy, with a median overall survival approaching
gain631
发表于 2025-3-23 03:34:55
https://doi.org/10.1007/978-3-030-46420-2tients with colorectal primaries, major complication rates range from 31% to 47% in patients with HI and 11% to 31% in patients without HI. Thirty-day mortality in patients with HI ranges from 0 to 3%, and 0.6% to 5% in patients without HI. Median OS is 13 to 35.3 months in patients with HI, and fro
BOLT
发表于 2025-3-23 09:31:24
stigation are presented to inform the direction of the field. .. ..Cancer Regional Therapy. summarizes the history, current technology, common procedures, and future prospects in this field and includes procedures from many surgical and interventional radiologic disciplines..978-3-030-28893-8978-3-030-28891-4